Form 4: Perspective Therapeutics Insider Sells Shares
Insider Transaction (Form 4)
Lantheus Alpha Therapy, LLC and 1 other reported changes in beneficial ownership of Perspective Therapeutics, Inc. common stock on September 3, 2026.
Summary
- Open-market sale: disposed of 80,783 Common Stock at $3.11 ($250,896) on September 3, 2026; holds 11,440,513 after (Direct).
- Open-market sale: disposed of 167,149 Common Stock at $3.15 ($526,051) on September 4, 2026; holds 11,273,364 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $776,947 of stock on the open market.
Insider Transactions
Lantheus Alpha Therapy, LLC — 10% owner
Lantheus Holdings, Inc. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market sale | Common Stock | 80,783 | $3 | $250.9K | 11,440,513 |
| 2026-09-04 | Open-market sale | Common Stock | 167,149 | $3 | $526.1K | 11,273,364 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market sale (80,783 shares) |
| 2026-09-04 | Open-market sale (167,149 shares) |
Keywords
insider transaction, Form 4, CATX, Perspective Therapeutics, Inc., bearish, Lantheus Alpha Therapy, LLC, Lantheus Holdings, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.